Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens.

about

Classification of current anticancer immunotherapies Trial watch: Naked and vectored DNA-based anticancer vaccines Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.

P2860

Q35149637-58C10C69-C1A7-4FA0-A5B2-FCBE44899A35 Q35798986-1F2C2A07-CD86-433E-B295-4F5313DDFB0B Q37697593-728F9B35-96EC-4EAE-9344-4F87265CBD4A

P2860

Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens.

Item

http://www.wikidata.org/entity/Q42079459

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Vaccination of biliary tract c ...... d from cancer-testis antigens.

@en

Vaccination of biliary tract c ...... d from cancer-testis antigens.

@nl

type

Item

label

Vaccination of biliary tract c ...... d from cancer-testis antigens.

@en

Vaccination of biliary tract c ...... d from cancer-testis antigens.

@nl

prefLabel

Vaccination of biliary tract c ...... d from cancer-testis antigens.

@en

Vaccination of biliary tract c ...... d from cancer-testis antigens.

@nl

P1476

Vaccination of biliary tract c ...... d from cancer-testis antigens.

@en

P2093

Atsushi Aruga

http://www.w3.org/2001/XMLSchema#string

P2860

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer.

Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.

Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer.

Clinical evaluation of therapeutic cancer vaccines.

The immune score as a new possible approach for the classification of cancer.

Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer.

Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival.

Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer.

P304

e24882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.24882

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257136352

http://www.w3.org/2001/XMLSchema#string

P698

24073370

http://www.w3.org/2001/XMLSchema#string

P932

3782136

http://www.w3.org/2001/XMLSchema#string

Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens.

about

P2860

P2860

Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932